Avinger Inc.

0.9700-0.1300-11.82%Vol 5.09M1Y Perf 145.14%
Apr 20th, 2021 16:00 DELAYED
BID0.9600 ASK0.9700
Open1.08 Previous Close1.10
Pre-Market- After-Market0.97
 - -  - -%
Target Price
2.50 
Analyst Rating
Moderate Buy 2.00
Potential %
157.73 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
     41.23
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★     45.20
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Market Cap92.44M 
Earnings Rating
Neutral
Price Range Ratio 52W %
30.78 
Earnings Date
12th May 2021

Today's Price Range

0.94001.10

52W Range

0.21392.67

5 Year PE Ratio Range

-0.7000-0.1000

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-24.22%
1 Month
-43.60%
3 Months
-53.59%
6 Months
224.52%
1 Year
145.14%
3 Years
-92.30%
5 Years
-99.98%
10 Years
-

TickerPriceChg.Chg.%
AVGR0.9700-0.1300-11.82
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Financial StrengthValueIndustryS&P 500US Markets
3.20
3.70
0.49
1.30
-10.20
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
29.90
-207.90
-197.30
-312.20
-
RevenueValueIndustryS&P 500US Markets
6.50M
0.07
3.28
-12.05
Earnings HistoryEstimateReportedSurprise %
Q04 2020--0.07-
Q03 2020--0.08-
Q02 2020--0.18-
Q01 2020--0.47-
Q04 2019--0.58-
Q03 2019--0.70-
Q02 2019--0.87-
Q01 2019--1.40-
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.380.00-
12/2017 QR-0.370.00-
12/2021 FY-0.22-4.76Negative
12/2022 FY-0.20-17.65Negative
Next Report Date12th May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume5.09M
Shares Outstanding95.30M
Trades Count9.26K
Dollar Volume10.12M
Avg. Volume17.61M
Avg. Weekly Volume3.61M
Avg. Monthly Volume3.27M
Avg. Quarterly Volume9.53M

Avinger Inc. (NASDAQ: AVGR) stock closed at 0.97 per share at the end of the most recent trading day (a -11.82% change compared to the prior day closing price) with a volume of 5.55M shares and market capitalization of 92.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 81 people. Avinger Inc. CEO is Jeffrey M. Soinski.

The one-year performance of Avinger Inc. stock is 145.14%, while year-to-date (YTD) performance is 120.4%. AVGR stock has a five-year performance of -99.98%. Its 52-week range is between 0.2139 and 2.67, which gives AVGR stock a 52-week price range ratio of 30.78%

Avinger Inc. currently has a PE ratio of -1.60, a price-to-book (PB) ratio of 8.31, a price-to-sale (PS) ratio of 16.13, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -77.36%, a ROC of -80.82% and a ROE of -222.24%. The company’s profit margin is -%, its EBITDA margin is -197.30%, and its revenue ttm is $6.50 Million , which makes it $0.07 revenue per share.

Of the last four earnings reports from Avinger Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Avinger Inc.’s next earnings report date is 12th May 2021.

The consensus rating of Wall Street analysts for Avinger Inc. is Moderate Buy (2), with a target price of $2.5, which is +157.73% compared to the current price. The earnings rating for Avinger Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avinger Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avinger Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.54, ATR14 : 0.20, CCI20 : -181.75, Chaikin Money Flow : -0.05, MACD : -0.12, Money Flow Index : 27.38, ROC : -27.15, RSI : 35.60, STOCH (14,3) : 7.55, STOCH RSI : 0.00, UO : 34.72, Williams %R : -92.45), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avinger Inc. in the last 12-months were: Himanshu N. Patel (Option Excercise at a value of $0), Himanshu N. Patel (Sold 9 686 shares of value $3 468 ), James B. Mcelwee (Option Excercise at a value of $0), James G. Cullen (Option Excercise at a value of $0), Jeffrey M. Soinski (Option Excercise at a value of $0), Jeffrey M. Soinski (Sold 15 127 shares of value $5 443 ), Mark Weinswig (Option Excercise at a value of $0), Mark Weinswig (Sold 9 088 shares of value $3 226 ), Tamara N. Elias (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Strong Buy
1.00

Avinger Inc.

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

CEO: Jeffrey M. Soinski

Telephone: +1 650 241-7900

Address: 400 Chesapeake Drive, Redwood City 94063, CA, US

Number of employees: 81

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

63%38%

Bearish Bullish

67%33%

Bearish Bullish

59%41%

News

Stocktwits